Eveno Clarisse, Nemeth Judith, Soliman Hany, Praz Françoise, de The Hugues, Valleur Patrice, Talbot Ian C, Pocard Marc
Département Medico-Chirurgical de Pathologie Digestive, Assistance Publique des Hôpitaux de Paris, Hôpital Lariboisière, Université Paris, France.
Arch Surg. 2010 Jan;145(1):12-7. doi: 10.1001/archsurg.2009.224.
Stage I or II colorectal carcinomas with microsatellite instability (MSI) are characterized by more isolated lymph nodes in the resected specimen than their counterparts with microsatellite stability (MSS).
Prospective study.
Academic research.
Using a pentaplex polymerase chain reaction assay, MSI status was determined prospectively for 135 operative patients.
Mismatch repair defects were investigated by immunohistochemistry on tumors demonstrating MSI.
Among 82 stage I or II colorectal carcinomas, 11 had MSI, and 71 had MSS, with a mean (SD) number of 23.6 (3.1) and 13.7 (1.0) negative lymph nodes, respectively (P = .001). The mean number of lymph nodes for all resected stage I or II colorectal carcinomas analyzed at our hospital was 15. The prevalence of MSI among tumors with more than 15 lymph nodes in the specimen was 25% (9 of 36), and 82% (9 of 11) of MSI tumors belonged to this group.
A high number of isolated lymph nodes in stage I or II colorectal carcinomas was associated with the MSI phenotype. Good prognosis that is usually associated with tumors having a high number of uninvolved lymph nodes might reflect the high prevalence of MSI among these tumors. The number of examined lymph nodes as a quality criterion should be used with caution. For stage I or stage II colorectal carcinomas, restricting MSI phenotyping to tumors with more than the mean number of lymph nodes identifies almost all MSI tumors.
与微卫星稳定(MSS)的I期或II期结直肠癌相比,微卫星不稳定(MSI)的I期或II期结直肠癌在切除标本中的孤立淋巴结更多。
前瞻性研究。
学术研究。
使用五重聚合酶链反应检测法,对135例手术患者前瞻性地确定MSI状态。
通过免疫组织化学对显示MSI的肿瘤进行错配修复缺陷研究。
在82例I期或II期结直肠癌中,11例为MSI,71例为MSS,阴性淋巴结的平均(标准差)数量分别为23.6(3.1)和13.7(1.0)(P = 0.001)。我院分析的所有切除的I期或II期结直肠癌的淋巴结平均数量为15个。标本中淋巴结超过15个的肿瘤中MSI的患病率为25%(36例中的9例),82%(11例中的9例)的MSI肿瘤属于该组。
I期或II期结直肠癌中大量孤立淋巴结与MSI表型相关。通常与未受累淋巴结数量多的肿瘤相关的良好预后可能反映了这些肿瘤中MSI的高患病率。作为质量标准的检查淋巴结数量应谨慎使用。对于I期或II期结直肠癌,将MSI表型分析限制在淋巴结数量超过平均数量的肿瘤中可识别几乎所有MSI肿瘤。